The early diagnosis of acute myocardial infarction (AMI) very soon after symptom onset remains a major clinical challenge, even when using high-sensitivity cardiac troponin (hs-cTnT).
Methods and results:
We investigated the incremental value of heart-type fatty acid-binding protein (hFABP) in a pre-specified subgroup analysis of patients presenting with suspected AMI within 1 h of symptom onset to the emergency department (ED) in a multicentre study. HFABP was measured in a blinded fashion. Two independent cardiologists using all available clinical information, including hs-cTnT, adjudicated the final diagnosis. Overall, 1411 patients were enrolled, of whom 105 patients presented within 1 h of symptom onset. Of these, 34 patients (32.4%) had AMI. The diagnostic accuracy as quantified by the area under the receiver-operating characteristics curve (AUC) of hFABP was high (0.84 (95% CI 0.74–0.94)). However, the additional use of hFABP only marginally increased the diagnostic accuracy of hs-cTnT (AUC 0.88 (95% CI 0.81–0.94) for hs-cTnT alone to 0.90 (95% CI 0.83–0.98) for the combination; p=ns). After the exclusion of 18 AMI patients with ST-segment elevation, similar results were obtained. Among the 16 AMI patients without ST-segment elevation, six had normal hs-cTnT at presentation. Of these, hFABP was elevated in two (33.3%) patients.
Conclusions:
hFABP does not seem to significantly improve the early diagnostic accuracy of hs-cTnT in the important subgroup of patients with suspected AMI presenting to the ED very early after symptom onset.
AndersonJLAdamsCDAntmanEM.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol2007; 50: e1–e157.
2.
HammCWBassandJPAgewallS.; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J2011; 32: 2999–3054.
3.
ThygesenKAlpertJSJaffeAS.; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, et al.; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J2012; 33: 2551–2567.
4.
WangKAsingerRWMarriottHJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med2003; 349: 2128–2135.
5.
ReichlinTSchindlerCDrexlerB. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med2012; 172: 1211–1218.
6.
AntmanEMCohenMBerninkPJ. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA2000; 284: 835–842.
7.
MorrowDAAntmanEMCharlesworthA. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation2000; 102: 2031–2037.
8.
SchoenenbergerAWRadovanovicDStaufferJC.; Acute Myocardial Infarction in Switzerland Plus Investigators. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: A cohort study. J Am Geriatr Soc2008; 56: 510–516.
9.
KellerTZellerTPeetzD. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med2009; 361: 868–877.
10.
ReiterMTwerenboldRReichlinT. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J2012; 33: 988–997.
11.
SearleJShihJMullerR. The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department. Eur Heart J Acute Cardiovasc Care2013; 2: 203–210.
12.
KleineAHGlatzJFVan NieuwenhovenFA. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem1992; 116: 155–162.
13.
LiebetrauCNefHMDörrO. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart2014; 100: 652–657.
14.
Bruins SlotMHReitsmaJBRuttenFH. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: A systematic review and meta-analysis. Heart2010; 96: 1957–1963.
15.
ShirakabeAKobayashiNHataN. Prognostic impact of the serum heart-type fatty acid-binding protein (H-FABP) levels in patients admitted to the non-surgical intensive care unit. Clin Res Cardiol2014; 103: 791–804.
16.
ReiterMTwerenboldRReichlinT. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart2013; 99: 708–714.
17.
KagawaYToyofukuMMasaokaY. Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction. Int J Cardiol2013; 166: 347–351.
18.
AppleFSCollinsonPO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem2012; 58: 54–61.
19.
SaengerAKBeyrauRBraunS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta2011; 412: 748–754.
20.
OhkaruYAsayamaKIshiiH. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods1995; 178: 99–111.
21.
ThygesenKMairJGiannitsisE.; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J2012; 33: 2252–2257.
22.
ErnePSchoenenbergerAWZuberM. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: The Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. Eur Heart J2007; 28: 2110–2117.
23.
DeLongERDeLongDMClarke-PearsonDL. Comparing the area under two or more correlated receiver operating curves: A nonparametric approach. Biometrics1988; 44: 837–845.
24.
ChanCPSumKWCheungKY. Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods2003; 279: 91–100.
25.
ViswanathanKKilcullenNMorrellC. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol2010; 55: 2590–2598.
26.
CappelliniFDa MolinSSignoriniS. Heart-type fatty acid-binding protein may exclude acute myocardial infarction on admission to emergency department for chest pain. Acute Card Care2013; 15: 83–87.
27.
KitamuraMHataNTakayamaT. High-sensitivity cardiac troponin T for earlier diagnosis of acute myocardial infarction in patients with initially negative troponin T test – comparison between cardiac markers. J Cardiol2013; 62: 336–342.
28.
CollinsonPOGazeDCThokalaP. Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation (RATPAC CBE). Health Technol Assess2013; 17: v–vi, 1–122.
29.
RuffCTBonacaMPKosowskyJM. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis2013; 36: 361–367.
30.
LippiGMattiuzziCCervellinG. Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction. Clin Biochem2013; 46: 26–30.
31.
BonacaMPRuffCTKosowskyJ. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care2013; 2: 195–202.
32.
SchoenenbergerAWBieriCÖzgülerO. A novel multidimensional geriatric screening tool in the ED: Evaluation of feasibility and clinical relevance. Am J Emerg Med2014; 32: 623–628.
33.
DanielHOeschPStuckAE. Evaluation of a novel photography-based home assessment protocol for identification of environmental risk factors for falls in elderly persons. Swiss Med Wkly2013; 143: w13884.
34.
SchoenenbergerAWFelberSGujerS. Invasive findings in patients with angina equivalent symptoms but no coronary artery disease; results from the heart quest cohort study. Int J Cardiol2013; 167: 168–173.
35.
Bruins SlotMHRuttenFHvan der HeijdenGJ. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care. Int J Cardiol2013; 168: 1485–1489.
36.
IshakMAliDFokkertMJ.; The FAMOUS TRIAGE Study Group. Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: Rationale and design. Eur Heart J Acute Cardiovasc Care. Epub ahead of print 8Sep2014.
